As the world continues to battle COVID-19, more and more countries are adopting measures to curb the spread of the virus. One such measure is self-testing, which has gained considerable popularity in recent times. Singapore is one such country that has approved the use of self-testing kits, and among them is the INDICAID COVID-19 Rapid Antigen Test. The test has received authorization from the Health Sciences Authority (HSA) of Singapore, making it available for use by consumers as a self-test.
An Overview of INDICAID COVID-19 Rapid Antigen Test
PHASE Scientific International LTD is the company behind INDICAID COVID-19 Rapid Antigen Test. Produced with state-of-the-art technology, this test is designed to detect the presence of the SARS-CoV-2 virus responsible for COVID-19 disease. With high accuracy and a short turnaround time, this test is set to be a game-changer in the fight against COVID-19.
The test utilizes an immunochromatographic assay to detect the presence of the virus in nasal swab samples. The test has a sensitivity of 95% and a specificity of 99.5%, meaning the chances of producing false positives or negatives are quite low. Furthermore, the test has obtained Emergency Use Authorization from the United States Food and Drug Administration (FDA) and CE-IVD certification from the European Union.
The decision by the Health Sciences Authority (HSA) of Singapore to authorize this test for consumer self-use is a massive boon for those in Singapore seeking to monitor their health regularly. The test can be performed easily and quickly, producing results in as little as 15 minutes.
PHASE Scientific International LTD is proud to be part of the COVID-19 response effort in Singapore by providing this valuable tool in the fight against COVID-19. The authorization by HSA is recognition of the company's unrelenting drive for innovation and excellence, which has led to the creation of INDICAID COVID-19 Rapid Antigen Test.
Lifecosm Biotech Limited - The Company Behind INDICAID
Lifecosm Biotech Limited is the parent company of PHASE Scientific International LTD. The company was established by a group of experts who have worked in the fields of biotechnology, medicine, and pathogenic microorganism detection for nearly 20 years. Since its inception, the company has been committed to providing innovative solutions in the field of healthcare and biotechnology.
In addition to INDICAID, Lifecosm Biotech Limited has produced several other innovative products, including Rapid-Flow Go Nucleic Acid Extraction Kit, Rapid-Flow Go Carrier RNA, and more. The company's mission is to provide access to advanced molecular diagnostic technology to the general public and make healthcare more accessible to all.
Conclusion
The approval of INDICAID COVID-19 Rapid Antigen Test for consumer self-use by the Health Sciences Authority (HSA) of Singapore is a significant step forward in the fight against COVID-19. With high accuracy and a short turnaround time, this test provides an essential tool for Singaporeans to monitor their health regularly.
Lifecosm Biotech Limited, the parent company of PHASE Scientific International LTD, is proud to be part of the COVID-19 response effort in Singapore. The company's innovative solutions in the field of healthcare and biotechnology have been vital in developing valuable tools like INDICAID COVID-19 Rapid Antigen Test.
As more countries continue to battle the spread of COVID-19, self-testing measures like INDICAID will likely become more prevalent. With companies like Lifecosm Biotech Limited leading the charge in developing innovative solutions, the fight against COVID-19 may soon turn in humanity's favor.